The use of proteomic technologies to study molecular mechanisms of multidrug resistance in cancer
Yi Cao1, Ziyin Li2, Lianzhi Mao2
1Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Lab of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan, 411105, China.
Abstract:
Multidrug resistance (MDR), defined as the cross-resistance of cancer cells toward a broad range of chemotherapeutic agents, is a universal and intractable problem in chemotherapy. The understanding of MDR mechanisms is essential to discover the potential biomarkers for predicting multidrug resistance and more importantly, tackling and preventing multidrug resistance. Multiple technologies have been used to study MDR mechanisms including comparative genomic hybridization, DNA array, differential display RT-PCR and various immunoassays. Compared with these approaches, proteomic technologies allow a high through-put analysis of protein detection, protein quantification and protein interaction with high accuracy. With the rapid development of proteomic studies in recent years, proteomic technologies have made substantial contributions to the characterization of MDR mechanisms including MDR-related protein detection and quantification, as well as the characterization of drug-transporter binding sites. This review offers a comprehensive illustration of MDR, proteomic technologies and the discoveries made in understanding MDR mechanisms using proteomic approaches.
Insights
Multidrug resistance (MDR) in cancer is a major challenge. Proteomic technologies offer advanced methods for understanding MDR mechanisms, aiding in the development of new cancer therapies.
Area of Science:
- Oncology
- Proteomics
- Biochemistry
Background:
- Multidrug resistance (MDR) is a significant obstacle in cancer chemotherapy, where cancer cells become resistant to various drugs.
- Understanding the mechanisms of MDR is crucial for developing strategies to overcome it and identify predictive biomarkers.
- Existing technologies for studying MDR have limitations in high-throughput analysis.
Purpose of the Study:
- To provide a comprehensive overview of multidrug resistance (MDR) in cancer.
- To illustrate the application and advantages of proteomic technologies in MDR research.
- To highlight recent discoveries in understanding MDR mechanisms through proteomic approaches.
Main Methods:
- Review of existing literature on multidrug resistance (MDR) mechanisms.
- Detailed explanation of various proteomic technologies applicable to MDR studies.
- Analysis of how proteomic approaches contribute to protein detection, quantification, and interaction studies relevant to MDR.
Main Results:
- Proteomic technologies enable high-throughput analysis of protein detection, quantification, and interactions with high accuracy.
- Proteomics has significantly contributed to identifying MDR-related proteins and characterizing drug-transporter binding sites.
- These advancements facilitate a deeper understanding of the molecular basis of multidrug resistance.
Conclusions:
- Proteomic technologies are powerful tools for elucidating complex MDR mechanisms in cancer.
- The application of proteomics is essential for discovering novel biomarkers and therapeutic targets for overcoming MDR.
- Continued advancements in proteomics will accelerate the development of more effective chemotherapy strategies.
More Related Videos
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
